Biotechnology News
Cutting edge news about companies engaged in the research and development of new drugs, medical devices and procedures as well as research, books and information on FDA approvals, patents and awards. Biotechnology news highlights the use of biological processes, organisms or systems to manufacture products that improve the quality of life.
Marcus Carr, Vice President at Pfizer to Keynote at GTCbio’s Cell & Gene Therapy Conference
Marcus Carr, Vice President at Pfizer, will give a keynote presentation on, “Clinical Development of Gene Therapy for Hemophilia B” at 3rd Cell & Gene Therapy. - July 21, 2016 - GTCbio
Bioscience Americas Outlines Growth Strategy
Opportunities abound for the world's leading developer of autologous stem cell treatment centers. - July 19, 2016 - Bioscience Americas
Hua Xu, Principal Scientist at Pfizer, to Present at Drug Design & Medicinal Chemistry Mtg
Hua Xu, Worldwide Medicinal Chemistry at Pfizer, to discuss “Chemical Biology Tools for Target Identification” at 11th Drug Design & Medicinal Chemistry Mtg. - July 19, 2016 - GTCbio
How to Commercialize Biosimilars? Case Studies from Boehringer Ingelheim, EMD Serono and Teva
SMi Group reports: Boehringer Ingelheim, EMD Serono and Teva will be presenting at this year’s Biosimilars North America meeting in New Jersey, USA on November 16 - 17. - July 15, 2016 - SAE Media Group
TJ Cradick from CRISPR Therapeutics to Present at GTCbio’s Cell & Gene Therapy Conference
TJ Cradick, Head of Genome Editing at CRISPR Therapeutics, to talk on, “Therapeutic Gene Editing with CRISPR/CAS9” at 3rd Cell & Gene Therapy Mtg - July 14, 2016 - GTCbio
Alfa Scientific Designs, Inc. to Introduce New Products and Driven Flow™ Technology During Exhibition Events in August
Alfa Scientific Designs, Inc., a leader in the development and manufacture of rapid immunoassay point-of-care tests, will be introducing its newest products featuring Driven Flow™ Technology during August at summer tradeshow events across the U.S. While attending the 68th American Association... - July 13, 2016 - Alfa Scientific Designs
Erin Keaney, at Novartis, to Present at Drug Design & Medicinal Chemistry
Erin Keaney, Global Discovery Chemistry at Novartis Institutes for BioMedical Research, will give a presentation at 11th Drug Design & Medicinal Chemistry. - July 12, 2016 - GTCbio
Richard Buller, VP at Pfizer, to Give a Keynote at GTCbio’s Biomarker Summit Europe 2016
Richard E. Buller, VP at Pfizer, will give a keynote presentation at GTCbio’s Biomarker Summit Europe 2016. - July 10, 2016 - GTCbio
Quantgene Achieves Breakthrough in Liquid Biopsy Early Cancer Detection by Combining Machine Learning with Next-Generation PCR
Quantgene announced a breakthrough in early cancer detection with a new approach to detect tumor DNA in standard blood samples that combines proprietary machine learning algorithms with next-generation polymerase chain reaction (PCR) technology. The Quantgene researchers analyzed large sets of... - July 08, 2016 - Quantgene
Dr. Stephen Chang to Present at CNS Diseases World Summit 2016
Dr. Stephen Chang, Vice President of R&D at NYSCF will give a presentation at GTCbio’s CNS Diseases World Summit 2016. - July 06, 2016 - GTCbio
An Update on Neurodegeneration Panel Discussion at CNS Diseases World Summit
Harry M. Tracy, President of NI Research will lead “An Update on Neurodegeneration...” panel at CNS Diseases World Summit 2016. - July 04, 2016 - GTCbio
Prosidyan Announces an Exclusive Joint Collaboration and License Agreement with MO-SCI Corporation for an Exciting New Technology
New Jersey based company Prosidyan, Inc. (www.prosidyan.com), developer of proprietary fiber-based bioactive glass orthobiologics products, announced today that it has entered into an exclusive joint collaboration and license agreement with MO-SCI Corporation of Rolla, Missouri for an exciting new... - June 30, 2016 - Prosidyan, Inc.
Michael Naso, Janssen R&D to Present at GTCbio’s Cell & Gene Therapy Conference
Michael Naso, Janssen R&D will discuss, “The Future of Biotherapeutics” at GTCbio’s 3rd Cell & Gene Therapy - June 30, 2016 - GTCbio
MiTeGen Announces Expansion of Manufacturing and R&D Facilities
MiTeGen LLC, a provider of innovative consumables for protein crystallization and X-ray diffraction to academic, pharmaceutical, industrial and government researchers around the world, announced facility expansions which include space for manufacturing of a new line of automated high-speed cryocooling devices, as well as dedicated areas for the manufacturing of CrystalDirect™ crystallization plates. - June 29, 2016 - MiTeGen, LLC
Judy Lieberman, Harvard Medical School to Keynote at Non-Coding RNA & RNAi Therapeutics
Judy Lieberman, Professor of Pediatrics at Harvard Medical School, will give a keynote presentation at GTCbio’s 7th Non-Coding RNA & RNAi Therapeutics Conference. - June 29, 2016 - GTCbio
Alfa Scientific Designs, Inc. Issued Patent for Driven Flow™ Technology
Patent covers new, high-accuracy diagnostic tool that delivers testing results in seconds. - June 28, 2016 - Alfa Scientific Designs
Spaulding Clinical to Disrupt Cardiac Safety Industry with Latest Innovation at DIA 2016
Wireless, hand-held electrocardiograph designed to simplify the collection and transmission of ECG data for Pharmaceutical Sponsors is going to be exhibited at the Drug Informatoin Association's (DIA) 2016 conference. - June 25, 2016 - Spaulding Clinical Research, LLC
Are You Ready for the Fast Approaching Compliance Date for UDI?
Maetrics unveils the current landscape of UDI in the USA and the substantial benefits of early compliance in latest free whitepaper. - June 25, 2016 - Maetrics
Biomarker Market for Diagnostic Applications is Expected to Reach $30.6 Billion Globally by 2020
Biomarkers are novel diagnostic tools that provide intelligence to physician about disease progression and treatment effects. Advancement in understanding of human genome promotes its application in diagnosis of disease on molecular basis. Biomarker technology is evidencing increased application in disease diagnosis, drug development and formulation, diagnosis for exposure of certain harmful chemical and prognostic treatments. - June 19, 2016 - Allied Market Research
Atlantis Health Care Group to Launch Cultural Exchange Program to Develop First Dialysis STEM Platform in Puerto Rico
Atlantis Health Care Group to launch cultural exchange program to develop first dialysis STEM platform in Puerto Rico. Undergraduate pre-licensure nursing students, dialysis patients, High School and Middle School students from the mainland US and Puerto Rico will participate in the first dialysis science, technology, engineering and technology (STEM) educational program pilot. DORADO, Puerto Rico – June 16, 2016 -- Atlantis Health Care Group (AHG), University of Puerto Rico Mayague - June 17, 2016 - Launch Team Consulting
IQ4I Research & Consultancy Published a New Report on “PCR Technologies Global Market – Forecast To 2022”
Polymerase Chain Reaction is a process in which multiple copies of desired DNA sequence is obtained in a short period of time. The factors driving the growth of this market are increasing demand for innovative technology supporting early and accurate diagnosis of life threatening disease, rising demand for PCR in genetic and molecular testing and expiry of key players PCR patents. - June 17, 2016 - IQ4I Research & Consultancy Pvt. Ltd.
Virun® Receives U.S. Patent 9,351,517 for Its Vitamin E, Esolv®, All-the-While Rebranding Itself as a Notable Formulation and Development Giant
Soon after international patent approval, Virun receives U.S. patent 9,351,571 for its principle technology, Esolv®. As research continues to show oils, fats and non-polar compounds have strong and growing efficacious health claims, the need to incorporate these compounds into foods, beverages and supplements will become even more sought-after. VIRUN’s extensive Portfolio, including Esolv®, is accelerating innovation. What Virun has created is notably notable in a noticeable way. - June 16, 2016 - VIRUN
AdvantaPure(R) Offers a New White Paper Focusing on Molded Tubing Connections; Illustrates the Risks and Expenses of Fluid Leaks in Biopharma Manufacturing Operations
Immediately available from high purity tubing manufacturer AdvantaPure is a report titled “How Molded Manifold Assemblies Prevent Leaks and Costly Consequences.” It addresses the risks and costs associated with tubing-to-fitting connection leaks and presents a solution, namely the use of molded connections. The white paper shows how critical leak risk becomes based on the number of connections in a manifold assembly. Additional white papers are available as well. - June 16, 2016 - AdvantaPure
IQ4I Research & Consultancy Published a New Report on “Cell-Free DNA (cfDNA) Testing Global Market – Forecast To 2022”
Cell-free DNA is used to detect chromosomal abnormalities in the foetuses for specific mutations, in cancer patients and graft rejection. During the process, sample with cell-free DNA in different forms are analyzed to get rapid and accurate results for early disease diagnosis. - June 13, 2016 - IQ4I Research & Consultancy Pvt. Ltd.
Spaulding Clinical Research Announces Addition to Cardiac Core Lab Management Team
Shane Braninburg joins cardiac safety solutions team to support growth initiatives. - June 09, 2016 - Spaulding Clinical Research, LLC
Spaulding Clinical Receives FDA 510(k) Clearance for 12-Lead ECG Device
With the FDA 510(k) Clearance for the 12-Lead ECG device - the Spaulding Clinical Electrocardiograph 2100iQ , Spaulding Medical, LLC can continue being the innovation leader in cardiac safety for patients, partners, and physicians. - June 02, 2016 - Spaulding Clinical Research, LLC
Healthcare Executive Search Company, Berke Executive Search, Announces Chronic Obstructive Pulmonary Disease Market to Face Challenges in 2016 and Beyond
At the end of 2015, experts assessed the global market for Chronic Obstructive Pulmonary Disease (COPD) treatments. Their analysis showed strong growth in the sector, with total research funding set to increase on a compounded annual rate of 2.9 percent, reaching $11.2 billion by 2021. Interest in the disease sparked a steady increase in executive searches for candidates with experience in the field. - June 02, 2016 - Berke Executive Search
BÜHLMANN Laboratories AG Announces New Health Canada License for the BÜHLMANN fCAL® turbo Assay
BÜHLMANN Laboratories AG's immunoturbidimetric assay for fecal calprotectin quantification, BÜHLMANN fCAL® turbo is now commercially available in Canada and is Health Canada licensed. - May 24, 2016 - BUHLMANN Diagnostics Corp
ValueCentric’s Training Conference, Focus 2016, Sells-Out in Record Time
ValueCentric, the leader in healthcare channel intelligence, today announced their annual user-training conference, being held in Princeton, NJ May 24th and 25th, has sold out. Anticipation for this event has accelerated with the company’s expanded data service offerings, a significant... - May 20, 2016 - ValueCentric
TriFoil Installs Russia’s First 3D Optical Imager in Novosibirsk
In February 2016, TriFoil Imaging in collaboration with GenMedica Baltic Ltd and assistance of BioVitrum Ltd installed Russia’s first 3D Optical imaging system, the InSyTe FLECT/CT. The system was installed under the operation of Prof. Evgeny Zavyalov, head of SPF Vivarium Department of... - May 17, 2016 - TriFoil Imaging
Robert W. Mcintosh, Ph.D. Recognized as One of the Top 10 Men of the Year by Strathmore's Who's Who Worldwide Publication
Robert W. McIntosh, Ph.D. of Pearl City, Hawaii has been recognized as one of the Top 10 Men of the Year for 2016 by Strathmore’s Who’s Who Worldwide for his outstanding contributions and achievements in the fields of research and development in basic neurosciences and governmental... - May 12, 2016 - Strathmore Worldwide
Jivana Biotechnology Inc Adds Dr David Jablons to Its Advisory Committee
Dr David Jablons Brings Thoracic Surgical Oncology and Lung Cancer Drug Development Experience to The Jivana Advisory Committee. - May 06, 2016 - Jivana Biotechnology Inc
Emport LLC Introduces AlerTox Sticks Mustard Rapid Allergen Test Kit
The AlerTox Sticks line of easy, on-site allergen detection kits now includes a test especially for mustard: AlerTox Sticks Mustard. The kit is designed for food manufacturers whose foods, beverages and surfaces may become contaminated with mustard. - May 02, 2016 - Emport, LLC
Morgan's Fund Issues Statement on Selection for NORD's Natural History Studies Project
A statement was issued today by Stephanie M. Vaughan, Co-founder and President of The Morgan Leary Vaughan Fund (Morgan’s Fund), regarding the announcement of the National Organization for Rare Disorders’ (NORD) selection of Natural History Studies Project participants. - April 22, 2016 - The Morgan Leary Vaughan Fund, Inc.
Michael Seaman of Harvard to Give Keynote at GTCbio’s Antiviral Drugs Conference
Harvard’s Michael Seaman talk is entitled “Choosing Optimal Combinations of Broadly Neutralizing Antibodies for Prevention and Treatment of HIV-1 Infection.” - April 22, 2016 - GTCbio
ValueCentric’s Order Management Module Becomes Choice Solution for Top Pharma Manufacturers
ValueCentric, the industry leader in healthcare channel intelligence, announced today that their Order Management application surpassed a significant milestone of $200 billion in processed orders annually. Following two recent implementations, the company is now processing critical order data for... - April 22, 2016 - ValueCentric
San Diego Intellectual Property Management and Consulting Firm Established by Seasoned Patent Agent
WALLACH IP Management and Consulting announced a new business venture focused on professional patent protection services. Founder Dr. Brenda Wallach, who has nearly twenty years' experience advising cutting-edge companies, is filling a critical need for companies that must protect their intellectual property and do so at a reasonable cost. The firm specializes in the areas of biotechnology, pharmaceuticals, therapeutics, renewable biofuels and medical devices. - April 21, 2016 - WALLACH IP Management and Consulting
Jivana Biotechnology Inc Announces Additions to Its Advisory Committee
Jivana Biotechnology adds Patrick Sage and Dr Frank Facchini to its advisory committee. - April 16, 2016 - Jivana Biotechnology Inc
The New York Center for Nanomedicine Research, Inc. is Signing a Strategic Agreement to Provide Drug Delivery Systems to ICAHRIS in Canada
Strategic agreement for the development of nanoparticules with application in Cancer, Type 2 diabetes and inflammation. The NYCNMR is providing to ICAHRIS, its innovative platform dedicated to Nanomedicine. The NY center is located in the upcoming Bio-Cluster located in Buffalo NY. - April 14, 2016 - New York Center for Nanomedicine Research, Inc.
BreviTest Awarded Grant from National Institute on Drug Abuse to Optimize Device for Rapid Cannabis Testing
BreviTest Technologies has been awarded a $234,412 grant from the National Institute on Drug Abuse of the National Institutes of Health (NIH) to explore rapid testing for THC, the main active ingredient in cannabis. The federal funds, awarded under the NIH’s Small Business Innovation Research... - April 14, 2016 - Cayman Chemical Company
Virun® at Ingredient Marketplace, Patent Grant in S. Korea, New Product Launches, Debut of Lightbulb Virun T-Shirts, and Webinar Controversy
VIRUN® plans on taking Orlando by storm at Ingredient Marketplace, where Virun’s Esolv® technology will take center stage, and Virun’s unique Omega smoothies and beverages will be available for sampling. South Korea granted Virun yet another patent protecting its unique technology. Virun launches new products and a new t-shirt. Virun’s latest webinar, “Inside Virun,” sparks controversy, and provides new business opportunities. - April 12, 2016 - VIRUN
Selsius and Alpine Security Partner to Offer Cybersecurity Training
High-profile data breaches at Target and eBay affected 70 million and 145 million consumers, respectively. Data breaches cost businesses $400 million in 2014 alone. These revelations from the 2015 Verizon Data Breach Investigations Report have led to a new partnership between Selsius™ Corporate & Career Training and Alpine Security. - April 08, 2016 - Alpine Security
ValueCentric Expands Specialty Data Quality and Performance Measurement Reporting Capabilities
Dashboards and reports are now available to Specialty manufacturer clients through the ValueTrak Platform. - April 07, 2016 - ValueCentric
ALPCO's New Chemiluminescent IL-6 ELISA Delivers Flexibility and Cost Savings
ALPCO announced the launch of its new STELLUX® Chemi Human IL-6 ELISA - the first cytokine assay in the STELLUX® Chemiluminescence product line. - April 06, 2016 - ALPCO
African Biosciences Inc. Launches First Ever E-Commerce Platform for Bioscience Reagents and Supplies in Nigeria
African Biosciences Ltd., a subsidiary of US-based African Biosciences Inc. today announced the launching of the first ever e-commerce platform in Nigeria to provide reagents and supplies to the bioscience and clinical research community. African Biosciences Ltd. is the first company to use an e-commerce driven model to deliver reagents and supplies to meet the needs of researchers into the biology of animals, humans, microbes and plants and medical testing laboratories in Nigeria. - April 04, 2016 - African Biosciences Inc.
Global Medical Solutions to Sell China Operations to Yantai Dongcheng Biochemicals
Global Medical Solutions to sell China Operations to Yantai Dongcheng Biochemicals and enter into a long-term collaborative partnership in China. - March 28, 2016 - Global Medical Solutions
Reilly H. Stewart Honored on the Reuter's Billboard in Times Square, New York City by Strathmore's Who's Who Worldwide Publication
Reilly H. Stewart of Indio, California was honored on the Reuter’s Billboard in Times Square in New York City by Strathmore’s Who’s Who Worldwide for his outstanding contributions and achievements in the field of healthcare. He has also been recognized as a Professional of the... - March 25, 2016 - Strathmore Worldwide
Hematogenix Laboratory Services, LLC Announces the Availability of FDA Approved PD-L1 Companion Diagnostic Tests
Hematogenix Laboratory Services Announces the Availability of PD-L1 Companion Diagnostic Tests for KEYTRUDA®, Merck's Anti-PD-1 Therapy for Metastatic Non-Small Cell Lung Cancer Whose Tumors Express PD-L1 with Disease Progression on or after Platinum-Containing Chemotherapy as well as a PD-L1 Complementary Diagnostic Test to Support Bristol-Myers Squibb's OPDIVO® Anti-PD-1 Therapy for Non-Squamous Non-Small Cell Lung Cancer. - March 24, 2016 - Hematogenix
MiTeGen Announces Their In Situ-1 Crystallization Plates Have Been Selected for Use in Microgravity Crystallization Experiments Aboard the International Space Station
MiTeGen LLC, a provider of innovative consumables for protein crystallization and X-ray diffraction to academic, pharmaceutical, industrial and government researchers around the world, announced that a line of their products, the In Situ-1™ crystallization plates, will be used for research conducted on the International Space Station (ISS). - March 24, 2016 - MiTeGen, LLC
Prism Medical & Design Secures CE Mark for Its ProteXsure Safety Capsule System
Prism Medical Nabs CE Mark for ProteXsure Safety Capsule System. Prism Medical has secured the CE mark for its ProteXsure Safety Capsule System, intended for the prevention of needle stick injuries. The approval is the first indication for the company’s Prism platform. - March 24, 2016 - Prism Medical & Design